Charlotte Larsson, Reba Kanungo, Gunnar Kahlmeter, R

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Characteristics of pathogenic Neisseria meningitidis in Moscow: prevalence of ‘non- European’ strains  Irina S. Koroleva, Alexander E. Platonov, Arie van.
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Atypical respiratory pathogens
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Hydatid disease Clinical Microbiology and Infection
Didier Guillemot, Claude Carbon  Clinical Microbiology and Infection 
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Training for the infectious diseases speciality in Norway
Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time.
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter 
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
A. Bryskier  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model  Karl Ekdahl, Otto Cars  Clinical Microbiology.
Community-acquired pneumonia: epidemiologic and clinical consideration
Vaccinations against respiratory tract infections at Hajj
Definition of the Clinical Antibacterial Spectrum of Activity
Clinical infection services—the Leiden experience
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Overview of cefixime use in community-acquired infections
Brita Bruun, Henrik Westh, Jørgen Stenderup 
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
Sanford Chodosh  Clinical Microbiology and Infection 
The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece  J. Papaparaskevas, J. Stefanou, A. Vatopoulos,
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Carratalà J.   Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
N.C. Weightman, S. Mitra, P.T. Kipling 
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
G. Kahlmeter  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Fernando Baquero, John F
The future of diagnostic bacteriology
Presentation transcript:

High frequency of multiresistant respiratory tract pathogens at community level in South India  Charlotte Larsson, Reba Kanungo, Gunnar Kahlmeter, R. Sambasiva Rao, Ingela Krantz, S. Ragnar Nonby, Håkan Miörner  Clinical Microbiology and Infection  Volume 5, Issue 12, Pages 740-747 (December 1999) DOI: 10.1111/j.1469-0691.1999.tb00707.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Histograms of antibiotic inhibition zones of S. pneumoniae isolates recovered from outpatients with ARI from India (filled ban) and from Sweden (open ban). Zone breakpoints for S. pneumoniae, recommended by the SRGA, are indicated by dotted lines. Clinical Microbiology and Infection 1999 5, 740-747DOI: (10.1111/j.1469-0691.1999.tb00707.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Histograms of antibiotic inhibition zones of H. influenzae isolates recovered from outpatients with ARI from India (filled bars) and from Sweden (open bars). Zone breakpoints for H. influenzae, recommended by the SRGA, are indicated by dotted lines. Clinical Microbiology and Infection 1999 5, 740-747DOI: (10.1111/j.1469-0691.1999.tb00707.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Histograms of antibiotic inhibition zones of M. catarrhalis isolates recovered from outpatients with ARI from India (filled bars) and from Sweden (open bars). Zone breakpoints for M. catarrhalist recommended by the SRGA, are indicated by dotted lines. Clinical Microbiology and Infection 1999 5, 740-747DOI: (10.1111/j.1469-0691.1999.tb00707.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.